Nimodipine accelerates the restoration of functional hyperemia during spreading oligemia
Journal of Neurochemistry · 2024
DOI: 10.1111/jnc.15792 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2024. Verfasst von Ákos Menyhárt und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hungarian Centre of Excellence for Molecular Medicine-University of Szeged, Cerebral Blood Flow and Metabolism Research Group, Szeged, Hungary. Hauptthemen laut MEDLINE: Nimodipine, Hyperemia, Mice, Inbred C57BL, Cortical Spreading Depression. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU's Horizon 2020 research and innovation program, Ministry of Human Capacities of Hungary, Ministry of Innovation and Technology of Hungary and the National Research, Development and Innovation Fund.
Abstract (Originalsprache)
Spreading depolarization (SD) is assumed to be the pathophysiological correlate of migraine aura, leading to spreading depression of activity and a long‐lasting vasoconstriction known as spreading oligemia. Furthermore, cerebrovascular reactivity is reversibly impaired after SD. Here, we explored the progressive restoration of impaired neurovascular coupling to somatosensory activation during spreading oligemia. Also, we evaluated whether nimodipine treatment accelerated the recovery of impaired neurovascular coupling after SD. Male, 4–9‐month‐old C57BL/6 mice ( n = 11) were anesthetized with isoflurane (1%–1.5%), and SD was triggered with KCl through a burr hole made at the caudal parietal bone. EEG and cerebral blood flow (CBF) were recorded minimally invasively with a silver ball electrode and transcranial laser‐Doppler flowmetry, rostral to SD elicitation. The L‐type voltage‐gated Ca 2+ channel blocker nimodipine was administered i.p. (10 mg/kg). Whisker stimulation‐related evoked potentials (EVPs) and functional hyperemia were assessed under isoflurane (0.1%)–medetomidine (0.1 mg/kg i.p.) anesthesia before, and repeatedly after SD, at 15‐min intervals for 75 minutes. Nimodipine accelerated the recovery of CBF from spreading oligemia (time to full recovery, 52 ± 13 vs. 70 ± 8 min, nimodipine vs. control) and exhibited a tendency to shorten the duration of the SD‐related EGG depression duration. The amplitudes of EVP and functional hyperemia were markedly reduced after SD, and progressively recovered over an hour post‐SD. Nimodipine exerted no impact on EVP amplitude but consistently increased the absolute level of functional hyperemia from 20 min post‐CSD (93 ± 11% vs. 66 ± 13%, nimodipine vs. control). A linear, positive correlation between EVP and functional hyperemia amplitude was skewed by nimodipine. In conclusion, nimodipine facilitated CBF restoration from spreading oligemia and the recovery of functional hyperemia post‐SD, which were linked to a tendency of an accelerated return of spontaneous neural activity after SD. The use of nimodipine in migraine prophylaxis is suggested to be re‐visited. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hungarian Centre of Excellence for Molecular Medicine-University of Szeged, Cerebral Blood Flow and Metabolism Research Group, Szeged, Hungary.
- Department of Cell Biology and Molecular Medicine, Albert Szent-Györgyi Medical School and Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.
- Department of Medical Physics and Informatics, Albert Szent-Györgyi Medical School and Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.
ORCID-Profile: Ákos Menyhárt, Eszter Farkas
Förderung
- EU's Horizon 2020 research and innovation program
- Ministry of Human Capacities of Hungary
- Ministry of Innovation and Technology of Hungary and the National Research, Development and Innovation Fund
- National Research, Development and Innovation Office of Hungary
- the University of Szeged Open Access Fund
Zitieren
APA
Menyhárt, Á., Bálint, A. R., Kozák, P., Bari, F., & Farkas, E. (2024). Nimodipine accelerates the restoration of functional hyperemia during spreading oligemia. Journal of Neurochemistry. https://doi.org/10.1111/jnc.15792
Vancouver
Menyhárt Á, Bálint AR, Kozák P, Bari F, Farkas E. Nimodipine accelerates the restoration of functional hyperemia during spreading oligemia. Journal of Neurochemistry. 2024. doi:10.1111/jnc.15792
BibTeX
@article{Menyhrt2024,
author = {Menyhárt, Ákos and Bálint, Armand Rafael and Kozák, Péter and Bari, Ferenc and Farkas, Eszter},
title = {Nimodipine accelerates the restoration of functional hyperemia during spreading oligemia},
journal = {Journal of Neurochemistry},
year = {2024},
doi = {10.1111/jnc.15792}
}
EUVIMED